Patent · US Active

Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system

US10058646B2 · kind B2 · utility

2Cited by

11References

33Claims

0Family size

Assignee

MACOPHARMA, S.A.S. · FR

Inventors

Wolfram Hubert Walker · Neuenstadt am Kocher, DE
Frank Tolksdorf · Ober-Ramstadt, DE
Thierry Verpoort · Halluin, FR
Francis Goudaliez · Faches-Thumesnil, FR

Key dates

Filing date	Mar 6, 2017
Grant date	Aug 28, 2018
Priority date	—
Expiry date	Mar 24, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M2207/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a blood bag system, a method for its manufacture, and a process for reducing pathogens and leucocytes in biological fluids in particular in therapeutic quantities of platelet concentrates (PC) contained in the blood bag system, using UV-light and agitation, wherein part of the plasma of the PC is optionally exchanged against a platelet additive solution.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.